Global Preimplantation Genetic Testing Market is Estimated to Reach US$ 575.0 Mn Revenue by 2022 end

Fact.MR Fact.MR

Rockville, US, 2018-May-01 — /EPR Network/ — A freshly compiled business intelligent report, titled Preimplantation Genetic Testing Market Research Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been publicized to the vast archive of Fact.MR online repository. This 170 page study delivers all the vital details and information required to know about preimplantation genetic testing market current as well as future prospects. The analysts of the study have gone through extensive research methodologies in order to generate data and information that reflects the latest market undercurrents and industry trends. For a deeper understanding of the market, a sub-category level analysis has been elaborated, by which readers and investors of the report will able to know that where the market stands to gain.

Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=292

Genetic Screening to Emerge as the Highly Preferred Test Type

Genetic screening is expected to be the highly preferred test type as compared to genetic diagnosis. Gaining nearly two-third of the share in terms of revenue towards 2017 end, genetic screening is estimated to create more than US$ 100 million incremental opportunity throughout the forecast period.

Specialized Clinics to Account for Maximum Share

Among all other end users of preimplantation genetic testing, specialized clinics are expected to experience strong growth. Specialized clinics are estimated to exceed US$ 200 million revenue towards 2022 end. Meanwhile, hospitals are also expected to witness impressive growth throughout the forecast period.

Preimplantation Genetic Testing to find Largest Application in Embryo HLA Typing for Stem Cell Therapy

Embryo HLA typing for stem cell therapy is expected to show healthy growth from throughout 2017-2022. Embryo HLA typing for stem cell therapy is estimated to create an incremental opportunity exceeding US$ 70 million during 2017-2022.

NGS Technology to Gain Maximum Traction in the Preimplantation Genetic Testing Market

Compared to the various other technologies, NGS is expected to be the technology gaining highest revenue share in the global preimplantation genetic testing market. NGS is estimated to exceed US$ 200 million revenue by 2022 end.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global preimplantation genetic testing market through 2022, which include Agilent Technologies Inc., Abbott Laboratories, CooperSurgical Inc., Oxford Gene Technology IP, Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Genea Limited, Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation.

Browse Full Report with TOC@ https://www.factmr.com/report/292/preimplantation-genetic-testing-market

Table of Contents:

  1. Global Preimplantation Genetic Testing Market – Executive Summary
  2. Global Preimplantation Genetic Testing Market Overview
    2.1. Introduction
    2.1.1. Global Preimplantation Genetic Testing Market Taxonomy
    2.1.2. Global Preimplantation Genetic Testing Market Definition
    2.2. Global Preimplantation Genetic Testing Market Size (US$ Mn) and Forecast, 2012-2022
    2.2.1. Global Preimplantation Genetic Testing Market Y-o-Y Growth
    2.3. Global Preimplantation Genetic Testing Market Dynamics
    2.4. Supply Chain
    2.5. Cost Structure
    2.6. Pricing Analysis
    2.7. Raw Material Sourcing Strategy and Analysis
    2.8. Service Provider List
    2.9. Key Participants Market Presence (Intensity Map) By Region
  3. Global Preimplantation Genetic Testing Market Analysis and Forecast By Test Type 
    3.1. Global Preimplantation Genetic Testing Market Size and Forecast By Test Type, 2012-2022
    3.1.1. Genetic Diagnosis Market Size and Forecast, 2012-2022
    3.1.1.1. Revenue (US$ Mn) Comparison, By Region
    3.1.1.2. Market Share Comparison, By Region
    3.1.1.3. Y-o-Y growth Comparison, By Region
    3.1.2. Genetic Screening Market Size and Forecast, 2012-2022
    3.1.2.1. Revenue (US$ Mn) Comparison, By Region
    3.1.2.2. Market Share Comparison, By Region
    3.1.2.3. Y-o-Y growth Comparison, By Region

Continued…….

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=292

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

Matched content

Editor’s pick